Z-007 - Zola Therapeutics
vidutolimod (CMP-001) - Regeneron
Keytruda (pembrolizumab) - Merck (MSD)
https://jitc.bmj.com/content/13/Suppl_2/A1042
 
Arthur M Krieg 1; Evan Walters 2; James Barsoum 3; Thomas Broome 4; Richard Fahrner 5; Jonathan Neidigh 6; Michael Mellas 7; Sue E Blackwell 8; George J Weiner 9; Carlos Chan 10
 
Oct 3, 2025